| | Author, year | Sample size (n, T/C) | Age (years) (mean ± SD or range) | Gender (F/M) | Cancer type | Treatment method | Intervention time | Outcome indicator (scale) | Quality |
| | Tai et al., 2020 [8] | 127, 62/65 | – | – | Metastatic cancer | Surgery + chemotherapy | 5 days | Anxiety (SAS) | B | | Gao and Luo, 2019 [9] | 84, 42/42 | T: 40–74; C: 41–75 | T: 19/23; C: 18/24 | Lung cancer | Chemotherapy | 8 days | Anxiety (SAS); depression (SDS) | B | | Hu et al., 2019 [10] | 100, 50/50 | T: 65.24 ± 8.45; C: 64.70 ± 9.65 | T: 18/32; C: 18/32 | Lung cancer | Chemotherapy | 21 days | CRF (RPFS); anxiety (SAS); depression (SDS) | B | | Huang and Zhao, 2019 [11] | 120, 60/60 | T: 58.25 ± 6.91; C: 59.13 ± 7.62 | T: 29/31; C: 32/28 | Uncertain | Surgery + chemotherapy | 8 weeks | CRF (RPFS); quality of life (EORTc QLQ-C30) | B | | Li et al., 2020 [12] | 108, 55/53 | T: 59.85 ± 10.34; C: 56.83 ± 11.06 | T: 28/27; C: 25/28 | Uncertain | Chemotherapy | 5 days | CRF (RPFS); quality of life (FACT-G) | B | | Wu et al., 2017 [13] | 113, 57/56 | T: 58.53 ± 8.42; C: 58.52 ± 10.65 | T: 15/42; C: 10/46 | Lung cancer | Chemotherapy | 28 days | CRF (RPFS); quality of life (EORTc QLQ-C30) | B | | Hou et al., 2017 [3] | 113, 57/56 | T: 58.06 ± 8.42; C: 58.27 ± 10.57 | T: 15/42; C: 10/46 | Lung cancer | Chemotherapy | 28 days | CRF (RPFS) | B | | Sun, 2011 [4] | 60, 30/30 | T: 58.0 ± 6.1; C: 57.4 ± 6.9 | T: 16/14; C: 18/12 | Gastrointestinal cancer | Chemotherapy | 7 days | CRF (RPFS) | B | | Hu et al., 2017 [14] | 113, 51/62 | T: 59.98 ± 8.51; C: 58.81 ± 10.50 | T: 15/36; C: 11/51 | Lung cancer | Chemotherapy | 28 days | Anxiety (SAS) | A |
|
|
Undetermined in cancer type refers to the original literature indicating the inclusion of patients with unspecified tumor types. Full compliance with the risk of bias in the Cochrane RCTs is grade “A” (high-quality), and partial compliance with the original studies is grade “B” (moderate quality). T, interventional group; C, control group; F, female, M, male; CRF, cancer-related fatigue; RCT, randomized controlled trial; SAS, Self-rating Anxiety Scale; RPFS, Revised Piper Fatigue Scale; SD, standard deviation; SDS, Self-rating Depression Scale; EORTc QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30.
|
